PCSK9 inhibition for primary prevention of ischaemic heart disease in heterozygous familial hypercholesterolaemia

To assess the effectiveness and safety of PCSK9 inhibitors in the primary prevention of IHD in people with HeFH.

This is a protocol.

Share/Save